Clinical trial
Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease
NCT05379348 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 14, 2022
- Completion date
- August 5, 2025
- Enrollment
- 1,423 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.